292 Is it safe to discontinue immunotherapy after a response in merkel cell carcinoma?

Tachiki, L. ; Zawacki, L. ; Hippe, D. ; Moshiri, Y. ; Alexander, N. ; Akaike, T. ; Doolittle-Amieva, C. ; Pulliam, T. ; Zaba, L. ; Bhatia, S. ; Nghiem, P.

Journal of investigative dermatology, 2022-08, Vol.142 (8), p.S50 [Periódico revisado por pares]

Texto completo disponível